HIGHLIGHTS
- who: Endothelin receptor antagonist Fibrosis and collaborators from the Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf and DZHK , Hamburg, Germany have published the research work: Increased afterload induces pathological cardiac hypertrophy: a new in vitro model, in the Journal: (JOURNAL)
- what: The aim of this study was to develop an experimental model that allows investigating the impact of_(AE) on work-performing muscles in vitro.
- how: The authors developed a new model of cardiac hypertrophy based on the EHT technology.
SUMMARY
The aim of this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.